<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/202344-a-liquid-nasal-pharmaceutical-composition by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 04 Apr 2024 23:44:31 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 202344:A LIQUID NASAL PHARMACEUTICAL COMPOSITION</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">A LIQUID NASAL PHARMACEUTICAL COMPOSITION</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention relates to- a liquid nasal pharmaceutical composition which comprises (a) one or more active substances suitable for nasal administration and selected from the group consisting of vasoconstrictors, antiallergic agents and corticosteroids, (b) sorbitol; (c) a water-solubleC1-C4-alkyl-cellulose derivative; (d) a vehicle which is present in an amount of&#x27; at least 90% (m/V) of the total composition, and which is selected from water and mixtures of water with propylene glycol, water with glycerol and water with both propylene glycol and glycerol, whereby in all said mixtures water is present in an amount of at least 95% (m/V); and (e) optionally one or more nasally acceptable excipients.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td> <br><br>
The present invention relates to a liquid nasal pharmaceutical composition. More specifically, it concerns liquid nasal formulations with improved moisturizing properties.<br>
The nasal administration of active substances is a widely used method of treatment. Active substances which come into consideration are, for example, vasoconstrictors, such as xylometazoline, or antiallergic agents, such as cromoglycic acid or H1 receptor antagonists, e.g. dimethindene maleate. Another group of possible active substances is e.g. corticosteroids, such as beclomethasone or fluticasone.<br>
The indications in which a certain nasally administered drug is to be applied are known in the art. For example, vasoconstrictors are e.g. used as nasal decongestants for alleviating the typical symptoms of common cold, like running nose, obstructed nose etc., or in rhinitis or sinusitis. Antiallergic agents and corticosteroids are e.g. used in antiallergic conditions, e.g. hay fever, or in anti-asthmatic or anti-inflammatory conditions.<br>
Nasal administration of active substances in liquid form, e.g. in the form of drops, a solution or a spray - opposite to nasal administration in gel form - is desirable inter alia because of a much better distribution of the active substances within the - partly tiny - nasal cavities and an easier handling and dosing, e.g. in pediatric or geriatric patients.<br>
However, upon administration of liquid nasal formulations often the patients are suffering from side-effects like burning, dryness, stinging of the nasal mucosa or sneezing. One of the reasons for this is that liquids - in contrast to gels - normally do not remain in the nasal cavities for a long period of time but are washed out fast.<br>
The present invention addresses these problems and provides liquid nasal formulations which do not only moisturize the nasal mucosa but also keep it sufficiently moisturized for a prolonged period of time. As a result, liquid nasal pharmaceutical compositions having excellent and prolonged moisturizing properties are obtained.<br><br><br><br><br>
WE CLAIM:<br>
1.	A liquid nasal pharmaceutical composition which comprises<br>
(a)	one or more active substances suitable for nasal administration and selected from the group consisting of vasoconstrictors, antiallergic agents and corticosteroids,<br>
(b)	sorbitol;<br>
(c)	a water-soluble C1-C4alkyl-cellulose derivative;<br>
(d)	a vehicle which is present in an amount of at least 90% (m/V) of the total<br>
composition, and which is selected from water and mixtures of water with propylene<br>
glycol, water with glycerol and water with both propylene glycol and glycerol,<br>
whereby in all said mixtures water is present in an amount of at least 95% (m/V); and<br>
(e)	optionally one or more nasally acceptable excipients.<br>
2.	The pharmaceutical composition according to claim 1, wherein the active substance<br>
(a) is selected from the group consisting of vasoconstrictors and antiallergic agents.<br>
3.	The pharmaceutical composition according to claim 1, wherein the active<br>
substances (a) represent a combination of a vasoconstrictor and an antiallergic agent.<br>
4.	The pharmaceutical composition according to claim 1, wherein the active substance (a) is selected from the group of vasoconstrictors consisting of xylometazoline, naphazoline, fenoxazoline, oxymetazoline, tetrahydrozoline, tramazoline, phenylephrine, ephedrine, epinephrine, and a nasally acceptable salt of any of these compounds.<br>
5.	The pharmaceutical composition according to claim 1, wherein the active substance (a) is selected from the group of vasoconstrictors consisting of xylometazoline, oxymetazoline and a nasally acceptable salt of any of these two compounds.<br><br>
6.	The pharmaceutical composition according to any one of claims 1 to 5, wherein sorbitol (b) is present in an amount of from 0.5 up to 5% (m/V) of the total composition.<br>
7.	The pharmaceutical composition according to any one of claims 1 to 6, wherein the water-soluble C1-C4-alkyl-cellulose derivative is selected from the group consisting of methyl cellulose and (hydroxy or carboxy)-substituted C-C4-alkyl-celluloses.<br>
8.	The pharmaceutical composition according to any one of claims 1 to 6, wherein the water-soluble C-C4-alkyl-cellulose derivative (c) is hydroxypropyl methyl cellulose.<br>
9.	The pharmaceutical composition according to any one of claims 1 to 8, wherein the water-soluble C1-C4-alkyl-cellulose derivative (c) is present in an amount of from 0.3 up to 1 % (m/V) of the total composition.<br><br>
10.	The pharmaceutical composition according to any one of claims 1 to 9, wherein the vehicle (d) is water.<br>
11.	The pharmaceutical composition according to any one of claims 1 to 10, which contains as nasally acceptable excipients (e) essentially the following components: sodium dihydrogen phosphate dihydrate and disodium phosphate dodecahydrate as buffering agents, disodium edetate as chelating agent, benzalkonium chloride as preservative, and sodium chloride as isotonicity regulator.<br>
12.	The pharmaceutical composition according to any one of claims 1 to 11, which contains as nasally acceptable excipients (e) essentially the following components: 0.3-0.7% sodium dihydrogen phosphate dihydrate and 0.12-0.25% disodium phosphate  dodecahydrate as buffering agents,   0.02-0.08%  disodium  edetate   as<br><br>
chelating agent, 0.005-0.02% benzalkonium chloride as preservative, and 0.20-0.60% sodium chloride as isotonicity regulator.<br>
13.	The pharmaceutical composition according to any one of claims 1 to 4 and 6 to 12,<br>
which consists essentially of 0.025-0.2% of one or more vasoconstrictors selected<br>
from the group consisting of xylometazoline, naphazoline, fenoxazoline,<br>
oxymetazoline, tetrahydrozoline, tramazoline, phenylephrine, ephedrine, epinephrine,<br>
and nasally acceptable salts of said compounds; 1.2-1.6% sorbitol, 0.3-0.7%<br>
hydroxypropyl methyl cellulose, 0.3-0.7% sodium dihydrogen phosphate dihydrate,<br>
0.12-0.25% disodium phosphate dodecahydrate, 0.02-0.08% disodium edetate, 0.005-<br>
0.02% benzalkonium chloride and 0.20-0.60% sodium chloride, the remainder being<br>
water.<br>
14.	The pharmaceutical composition according to claim 13, wherein the<br>
vasoconstrictor selected is xylometazoline hydrochloride.<br>
15.	The pharmaceutical composition according to any one of claims 1 to 14, which is<br>
in the form of drops, a solution, a spray or a metered-dose spray.<br><br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1hYnN0cmFjdC5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1jbGFpbXMgZmlsZWQucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-claims filed.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1jbGFpbXMgZ3JhbmQucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-claims grand.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1jb3JyZXNwb25kZW5jZSBvdGhlcnMucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-correspondence others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1kZXNjcmlwdGlvbiBjb21wbGV0ZSBmaWxlZC5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-description complete filed.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1mb3JtIDEucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1mb3JtIDI2LnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-form 26.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1mb3JtIDMucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1mb3JtIDUucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1vdGhlciBkb2N1bWVudHMucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-other documents.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtMDc1LWNoZS1wY3QucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-075-che-pct.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtNzUtY2hlLWNvcnJlc3BvbmRlbmNlIHBvLnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2000-75-che-correspondence po.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtNzUtY2hlLWRlc2NyaXB0aW9uIGNvbXBsZXRlLWdyYW50LnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2000-75-che-description complete-grant.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="202343-a-method-an-encoding-device-and-a-reading-device-for-encoding-an-input-information-stream-in-one-operation.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="202345-a-modified-particle-having-an-attached-halide-group-and-methods-of-making-the-same.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>202344</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>IN/PCT/2000/75/CHE</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>05/2007</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>02-Feb-2007</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>31-Oct-2006</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>12-May-2000</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>M/S. NOVARTIS CONSUMER HEALTH S.A</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>Rue de L&#x27;Etraz, CH-1260 Nyon</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>Matthias SEIDEL,</td>
											<td>Chasseralstrasse 13, CH-3063 Ittigen</td>
										</tr>
										<tr>
											<td>2</td>
											<td>Christopher BUCKLEY,</td>
											<td>Chemin Sous-Gay 6, CH-1291 Commugny</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K 9/00</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP1999/000555</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>1999-01-28</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>98810069.9</td>
									<td>1999-01-30</td>
								    <td>EUROPEAN UNION</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/202344-a-liquid-nasal-pharmaceutical-composition by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 04 Apr 2024 23:44:32 GMT -->
</html>
